Full Text View
Tabular View
No Study Results Posted
Related Studies
Randomized Double-Blind Clinical Trial of Rebamipide vs Esomeprazole in the Treatment of NSAID-induced Gastropathy
This study has been completed.
Study NCT00641004   Information provided by Otsuka Pharmaceutical, Inc., Philippines

First Received on March 18, 2008.   Last Updated on August 23, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
NSAID Induced Gastropathy
Additional conditions recognized in this trial
Stomach Diseases
More general conditions related to this trial
Digestive System Diseases
Gastrointestinal Diseases
Interventions listed in this trial
Rebamipide and Esomeprazole
Additional drug interventions recognized in this trial
Anti-Inflammatory Agents, Non-Steroidal
Omeprazole
Rebamipide
More general drug interventions related to this trial
Analgesics
Analgesics, Non-Narcotic
Anti-Inflammatory Agents
Anti-Ulcer Agents
Antioxidants
Antirheumatic Agents
Enzyme Inhibitors
Gastrointestinal Agents
Molecular Mechanisms of Pharmacological Action
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Otsuka Pharmaceutical, Inc., Philippines


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services